We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




31P Magnetic Resonance Spectroscopy a Useful Tool for Evaluating Early Acute Hepatic Radiation Injury

By HospiMedica International staff writers
Posted on 20 Jul 2009
A Chinese research team investigated whether changes of 31P magnetic resonance spectroscopy (MRS) in the liver with early acute radiation injury were related to the liver damage score (LDS) and pathologic changes. More...
They also determined the value of 31P MRS in detecting early acute hepatic radiation injury, and identified the most significant phosphorylated metabolite for detecting acute hepatic injury.

Acute hepatic radiation injury could lead to necrosis of hepatocytes, fatty degeneration, and hepatic fibrosis. At the present, the gold standard test is liver biopsy. However, this procedure is invasive, uncomfortable for the patients and sometimes results in serious complications. 31P MRS has been used to study liver metabolism in vivo for several years.

In the study, a research team led by Dr. Jian-Shan Mao from Zhejiang University (China) studied 30 rabbits that received different radiation doses (ranging 5-20 Gy), which were used to establish acute hepatic injury models. Blood biochemical tests, 31P MRS, and pathological examinations were carried out 24 hours after irradiation. The level of injury was evaluated according to LDS and pathology. Ten healthy rabbits served as controls. The MR examination was performed on a 1.5 T imager using a 1H/31P surface coil by the two-dimensional (2D) chemical shift imaging technique. The relative quantities of phosphomonoesters (PME), phosphodiesters (PDE), inorganic phosphate (Pi), and adenosine triphosphate (ATP) were measured.

The investigators, who published their study on June 14, 2009 in the World Journal of Gastroenterology, discovered that there were significant differences of ATP-relative quantification among control group, mild injured group, moderate injured group, and severe injured group, according to both LDS grading and pathologic grading, respectively, and it decreased progressively with the increased degree of injury (r = -0.723, p = 0.000).

The relative quantification of PME and Pi decreased significantly in the severe injured group, and the difference between the control group and severe injured group was significant (p < 0.05) according to LDS grading and pathologic grading, respectively. There were no significant differences among groups according to LDS grading, and no significant differences between the control group and experimental groups according to pathologic grading. Significant differences were only found in PDE/ATP between the moderate injured group, the severe injured group, the control group, and the mild injured group. No significant difference was found in other ratios of relative quantification of phosphorus metabolites.

These results, according to the investigators, indicate that 31P MRS is a useful technique to evaluate early acute hepatic radiation injury. The relative quantification of hepatic ATP levels, which can reflect the pathologic severity of acute hepatic radiation injury, is correlated with LDS. This study may be especially useful for allowing clinical identification of early acute hepatic injury with 31P MRS in the future.

Related Links:

Zhejiang University




Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Lead study author Ramy Ghanim (left) and co-author Joy Jackson test an small implantable device alongside Assistant Professor Alex Abramson. In a new Science paper, they describe a networking system that connects therapeutic implants and wearable devices by using the body’s natural conductivity to send tiny signals. (Photo courtest of Georgia Tech)

Bioelectronic Network Enables Devices to Communicate Through Body Tissue and Coordinate Therapy

Wearable sensors and implanted therapeutic devices can be difficult to coordinate when signals must pass through the body. Conventional wireless signals do not travel well through tissue, while the antennas... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.